Such vulnerabilities reveal systemic weaknesses, especially when drugs like Wegovy should only be prescribed under close clinical supervision. A significant concern is the prescription of Wegovy ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

Popular prescription ... Do people need to stay on the drug to prevent regaining the weight? That is what all the early data is telling us. They’ve done a number of studies and for people who have ...

You'll need insurance approval before filling your Ozempic prescription. With most insurance ... Many health insurance plans don't cover the weight loss drug Zepbound because it's so new. It was ...

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

New checks on people wanting drugs such as Wegovy or Mounjaro will include verifying their body mass index in a video ...

Fifteen widely used medications- including two super-popular weight loss ... new prices will go into effect in 2027. If successful, the result could be lower Medicare Part D prices for drugs ...

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

More research and development will likely improve the safety and efficacy of GLP-1-based drug therapies. New and better weight loss compounds may be discovered. But in the meantime, we need to ...

The Biden administration moved Friday to negotiate the prices Medicare pays for the blockbuster weight-loss drugs ... of a new Medicare initiative aimed at lowering prescription drug prices ...